The Influence of Surgical Approach to the Renal Mass on Renal Function

Urologic Clinics of North America

Volumn 39, Issue 2, 2012, Pages 191-198

  Lane, Brian R ^a,b,c   Whelan, Christopher M ^a,b  

^a SPECTRUM HEALTH   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c VAN ANDEL RESEARCH INSTITUTE   (United States)

Author keywords

Chronic kidney disease; Kidney neoplasms; Nephrectomy; Partial nephrectomy; Renal function

Indexed keywords

CHRONIC KIDNEY DISEASE; CRYOABLATION; DIABETES MELLITUS; DISEASE SURVEILLANCE; ELECTIVE SURGERY; GLOMERULUS FILTRATION RATE; HEART DISEASE; HUMAN; HYPERTENSION; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY TUMOR; LAPAROSCOPIC SURGERY; NEPHRECTOMY; OBESITY; PARTIAL NEPHRECTOMY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; RISK FACTOR; ROBOTICS; SURGICAL APPROACH; TREATMENT OUTCOME;

CARCINOMA, RENAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FUNCTION TESTS; KIDNEY NEOPLASMS; LAPAROSCOPY; MALE; NEPHRECTOMY; POSTOPERATIVE COMPLICATIONS; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84859514674     PISSN: 00940143     EISSN: 1558318X     Source Type: Journal    
DOI: 10.1016/j.ucl.2012.01.007     Document Type: Review

References (65)

1. National Kidney Foundation. The facts about chronic kidney disease (CKD). Available at: Accessed November 1, 2011. http://www.kidney.org/kidneydisease/ckd/index.cfm.
2. Lane B.R., Campbell S.C. Management of small renal masses. AUA Update 2009, 28(34):314-323.
3. Huang W.C., Levey A.S., Serio A.M., et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 2006, 7(9):735-740.
4. Lane B.R., Fergany A.F., Weight C.J., et al. Renal functional outcomes after partial nephrectomy with extended ischemic intervals are better than after radical nephrectomy. J Urol 2010, 184(4):1286-1290.
5. Go A.S., Chertow G.M., Fan D., et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004, 351(13):1296-1305.
6. Lane B.R., Poggio E.D., Herts B.R., et al. Renal function assessment in the era of chronic kidney disease: renewed emphasis on renal function centered patient care. J Urol 2009, 182(2):435-443. [discussion: 443-4].
7. Gill I.S., Desai M.M., Kaouk J.H., et al. Laparoscopic partial nephrectomy for renal tumor: duplicating open surgical techniques. J Urol 2002, 167(2 Pt 1). 469-75 [discussion: 475-6].
8. Rogers C., Sukumar S., Gill I.S. Robotic partial nephrectomy: the real benefit. Curr Opin Urol 2011, 21(1):60-64.
9. Campbell S.C., Novick A.C., Belldegrun A., et al. Guideline for management of the clinical T1 renal mass. J Urol 2009, 182(4):1271-1279.
10. Ljungberg B., Cowan N.C., Hanbury D.C., et al. EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 2010, 58(3):398-406.
11. Frank I., Blute M.L., Cheville J.C., et al. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 2003, 170(6 Pt 1):2217-2220.
12. Lane B.R., Babineau D., Kattan M.W., et al. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. J Urol 2007, 178(2):429-434.
13. Dulabon L.M., Lowrance W.T., Russo P., et al. Trends in renal tumor surgery delivery within the United States. Cancer 2010, 116(10):2316-2321.
14. Ibrahim H.N., Foley R., Tan L., et al. Long-term consequences of kidney donation. N Engl J Med 2009, 360(5):459-469.
15. Bijol V., Mendez G.P., Hurwitz S., et al. Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive renal failure. Am J Surg Pathol 2006, 30(5):575-584.
16. Campbell S.C., Lane B.R. Malignant renal tumors. Cambell-Walsh urology 2011, Saunders, Philadelphia (PA), p. 1413-74. Chapter 49. 10th edition. A.J. Wein, L.R. Kavoussi, A.C. Novick (Eds.).
17. Thompson R.H., Boorjian S.A., Lohse C.M., et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 2008, 179(2):468-471. [discussion: 472-3].
18. Weight C.J., Larson B.T., Fergany A.F., et al. Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol 2010, 183(4):1317-1323.
19. Sorbellini M., Kattan M.W., Snyder M.E., et al. Prognostic nomogram for renal insufficiency after radical or partial nephrectomy. J Urol 2006, 176(2):472-476. [discussion: 476].
20. Smart N.A., Titus T.T. Outcomes of early versus late nephrology referral in chronic kidney disease: a systematic review. Am J Med 2011, 124(11):1073-1080. e2.
21. Subramanian V.S., Stephenson A.J., Goldfarb D.A., et al. Utility of preoperative renal artery embolization for management of renal tumors with inferior vena caval thrombi. Urology 2009, 74(1):154-159.
22. Weight C.J., Lythgoe C., Unnikrishnan R., et al. Partial nephrectomy does not compromise survival in patients with pathologic upstaging to pT2/pT3 or high-grade renal tumors compared with radical nephrectomy. Urology 2011, 77(5):1142-1146.
23. Breau R.H., Crispen P.L., Jimenez R.E., et al. Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy. J Urol 2010, 183(3):903-908.
24. Woldu S.L., Barlow L.J., Patel T., et al. Single institutional experience with nephron-sparing surgery for pathologic stage T3bNxM0 renal cell carcinoma confined to the renal vein. Urology 2010, 76(3):639-642.
25. Kolla S.B., Ercole C., Spiess P.E., et al. Nephron-sparing surgery for pathological stage T3b renal cell carcinoma confined to the renal vein. BJU Int 2010, 106(10):1494-1498.
26. Lane B.R., Fergany A.F., Linehan W.M., et al. Should preservable parenchyma, and not tumor size, be the main determinant of the feasibility of partial nephrectomy?. Urology 2010, 76(3):608-609.
27. Lane B.R., Babineau D.C., Poggio E.D., et al. Factors predicting renal functional outcome after partial nephrectomy. J Urol 2008, 180(6):2363-2368. [discussion: 2368-9].
28. Thompson R.H., Lane B.R., Lohse C.M., et al. Every minute counts when the renal hilum is clamped during partial nephrectomy. Eur Urol 2010, 58(3):340-345.
29. Lane B.R., Russo P., Uzzo R.G., et al. Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function. J Urol 2011, 185(2):421-427.
30. Lane B.R., Gill I.S., Fergany A.F., et al. Limited warm ischemia during elective partial nephrectomy has only a marginal impact on renal functional outcomes. J Urol 2011, 185(5):1598-1603.
31. Thompson R.H., Lane B.R., Lohse C.M., et al. Comparison of warm ischemia versus no ischemia during partial nephrectomy on a solitary kidney. Eur Urol 2010, 58(3):331-336.
32. Gill I.S., Kavoussi L.R., Lane B.R., et al. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 2007, 178(1):41-46.
33. Ukimura O., Nakamoto M., Gill I.S. Three-dimensional reconstruction of renovascular-tumor anatomy to facilitate zero-ischemia partial nephrectomy. Eur Urol 2012, 61(1):211-217.
34. Ng C.K., Gill I.S., Patil M.B., et al. Anatomic renal artery branch microdissection to facilitate zero-ischemia partial nephrectomy. Eur Urol 2012, 61(1):67-74.
35. Gill I.S., Eisenberg M.S., Aron M., et al. "Zero ischemia" partial nephrectomy: novel laparoscopic and robotic technique. Eur Urol 2011, 59(1):128-134.
36. Benway B.M., Bhayani S.B., Rogers C.G., et al. Robot assisted partial nephrectomy versus laparoscopic partial nephrectomy for renal tumors: a multi-institutional analysis of perioperative outcomes. J Urol 2009, 182(3):866-872.
37. Seo I.Y., Choi H., Boldbaatr Y., et al. Operative outcomes of robotic partial nephrectomy: a comparison with conventional laparoscopic partial nephrectomy. Korean J Urol 2011, 52(4):279-283.
38. Reyes J.M., Smaldone M.C., Uzzo R.G., et al. Current status of robot-assisted partial nephrectomy. Curr Urol Rep 2012, 13(1):24-37.
39. Pierorazio P.M., Patel H.D., Feng T., et al. Robotic-assisted versus traditional laparoscopic partial nephrectomy: comparison of outcomes and evaluation of learning curve. Urology 2011, 78(4):813-819.
40. Kowalczyk K.J., Alemozaffar M., Hevelone N.D., et al. Partial clamping of the renal artery during robotic-assisted laparoscopic partial nephrectomy: technique and initial outcomes. J Endourol 2011, [Epub ahead of print].
41. Kaouk J.H., Hillyer S.P., Autorino R., et al. 252 robotic partial nephrectomies: evolving renorrhaphy technique and surgical outcomes at a single institution. Urology 2011, 78(6):1338-1344.
42. Hellenthal N.J., Underwood W., Penetrante R., et al. Prospective clinical trial of preoperative sunitinib in patients with renal cell carcinoma. J Urol 2010, 184(3):859-864.
43. Choi J.D., Park J.W., Choi J.Y., et al. Renal damage caused by warm ischaemia during laparoscopic and robot-assisted partial nephrectomy: an assessment using Tc 99m-DTPA glomerular filtration rate. Eur Urol 2010, 58(6):900-905.
44. Kang S., Bruhn A., Chandarana H., et al. Pre- and post-operative measurement of single kidney function in partial nephrectomy for renal masses using magnetic resonance renography [abstract 1080]. J Urol 2010, 185(4).
45. Lane B.R. Molecular markers of kidney injury. Urol Oncol 2011, [Epub ahead of print].
46. Finley D.S., Beck S., Box G., et al. Percutaneous and laparoscopic cryoablation of small renal masses. J Urol 2008, 180(2):492-498. [discussion: 498].
47. Long C.J., Kutikov A., Canter D.J., et al. Percutaneous vs surgical cryoablation of the small renal mass: is efficacy compromised?. BJU Int 2011, 107(9):1376-1380.
48. Matin S.F., Ahrar K. Nephron-sparing probe ablative therapy: long-term outcomes. Curr Opin Urol 2008, 18(2):150-156.
49. Haber G.P., Lee M.C., Crouzet S., et al. Tumour in solitary kidney: laparoscopic partial nephrectomy vs laparoscopic cryoablation. BJU Int 2012, 109(1):118-124.
50. Berger A., Kamoi K., Gill I.S., et al. Cryoablation for renal tumors: current status. Curr Opin Urol 2009, 19(2):138-142.
51. Carraway W.A., Raman J.D., Cadeddu J.A. Current status of renal radiofrequency ablation. Curr Opin Urol 2009, 19(2):143-147.
52. Kunkle D.A., Uzzo R.G. Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer 2008, 113(10):2671-2680.
53. Zagoria R.J., Childs D.D. Update on thermal ablation of renal cell carcinoma: oncologic control, technique comparison, renal function preservation, and new modalities. Curr Urol Rep 2012, 13(1):63-69.
54. Kunkle D.A., Egleston B.L., Uzzo R.G. Excise, ablate or observe: the small renal mass dilemma-a meta-analysis and review. J Urol 2008, 179(4):1227-1233. [discussion: 1233-4].
55. Turna B., Kaouk J.H., Frota R., et al. Minimally invasive nephron sparing management for renal tumors in solitary kidneys. J Urol 2009, 182(5):2150-2157.
56. Raman J.D., Raj G.V., Lucas S.M., et al. Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques. BJU Int 2010, 105(4):496-500.
57. Mitchell C.R., Atwell T.D., Weisbrod A.J., et al. Renal function outcomes in patients treated with partial nephrectomy versus percutaneous ablation for renal tumors in a solitary kidney. J Urol 2011, 186(5):1786-1790.
58. Mues A.C., Okhunov Z., Haramis G., et al. Comparison of percutaneous and laparoscopic renal cryoablation for small (<3.0 cm) renal masses. J Endourol 2010, 24(7):1097-1100.
59. Pettus J.A., Werle D.M., Saunders W., et al. Percutaneous radiofrequency ablation does not affect glomerular filtration rate. J Endourol 2010, 24(10):1687-1691.
60. Smaldone M.C., Kutikov A., Egleston B.L., et al. Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer 2011, [Epub ahead of print].
61. Crispen P.L., Viterbo R., Boorjian S.A., et al. Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer 2009, 115(13):2844-2852.
62. Abouassaly R., Lane B.R., Novick A.C. Active surveillance of renal masses in elderly patients. J Urol 2008, 180(2):505-508. [discussion: 508-9].
63. Crispen P.L., Wong Y.N., Greenberg R.E., et al. Predicting growth of solid renal masses under active surveillance. Urol Oncol 2008, 26(5):555-559.
64. Lane B.R., Abouassaly R., Gao T., et al. Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older. Cancer 2010, 116(13):3119-3126.
65. Almatur A, Margel D, Finelli T, et al. Natural history of renal function in untreated kidney cancer [abstract 137]. Urol Onc. Presented at SUO meeting. Bethesda (MD), December 5, 2011.